Published in JAMA on October 04, 2000
Electronic Health Records for Health Promotion | NCT00142077
Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature (2011) 11.07
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med (2006) 4.50
Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City. BMJ (2009) 4.31
Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio (2010) 4.15
Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog (2006) 3.82
IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog (2011) 2.99
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis (2006) 2.79
Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci U S A (2007) 2.72
Simulating school closure strategies to mitigate an influenza epidemic. J Public Health Manag Pract (2010) 2.59
Antibody landscapes after influenza virus infection or vaccination. Science (2014) 2.04
The effect of universal influenza immunization on mortality and health care use. PLoS Med (2008) 2.01
Quantifying influenza vaccine efficacy and antigenic distance. Vaccine (2006) 1.97
Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med (2013) 1.94
An evaluation of vignettes for predicting variation in the quality of preventive care. J Gen Intern Med (2004) 1.74
Influenza virus hemagglutinin stalk-based antibodies and vaccines. Curr Opin Virol (2013) 1.69
Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009. Ann Intern Med (2009) 1.68
Service implications of providing intensive monitoring during high-risk periods for suicide among VA patients with depression. Psychiatr Serv (2009) 1.68
Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med (2012) 1.64
Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. PLoS One (2013) 1.64
Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin Infect Dis (2009) 1.62
Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic. Emerg Infect Dis (2007) 1.59
Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis (2008) 1.58
Protecting health care workers: a pandemic simulation based on Allegheny County. Influenza Other Respir Viruses (2010) 1.58
Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine (2007) 1.58
A synthetic adjuvant to enhance and expand immune responses to influenza vaccines. PLoS One (2010) 1.57
Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J Virol (2009) 1.50
Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. J Virol (2013) 1.49
H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. J Virol (2013) 1.48
The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza Other Respir Viruses (2010) 1.47
How can nurses' flu vaccination rates be boosted? Nurs N Z (2009) 1.39
Influenza and cardiovascular disease: is there a causal relationship? Tex Heart Inst J (2004) 1.39
Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis. PLoS One (2011) 1.34
Prevention of influenza in the general population. CMAJ (2004) 1.32
Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. Influenza Other Respir Viruses (2008) 1.29
Influenza vaccination among healthcare workers: ten-year experience of a large healthcare organization. Infect Control Hosp Epidemiol (2010) 1.28
The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect (2005) 1.26
A national survey of physician practices regarding influenza vaccine. J Gen Intern Med (2002) 1.25
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population. Aging Dis (2011) 1.23
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc Natl Acad Sci U S A (2011) 1.23
Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza. Vaccine (2010) 1.19
Antiviral resistance during pandemic influenza: implications for stockpiling and drug use. BMC Infect Dis (2009) 1.17
The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons. MedGenMed (2007) 1.16
Self-reported influenza-like illness and receipt of influenza antiviral drugs during the 2009 pandemic, United States, 2009-2010. Am J Public Health (2012) 1.14
Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur J Clin Nutr (2011) 1.14
Surgical mask to prevent influenza transmission in households: a cluster randomized trial. PLoS One (2010) 1.13
Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporos Int (2004) 1.12
Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force Survey. BMC Infect Dis (2011) 1.11
Role of the primary care safety net in pandemic influenza. Am J Public Health (2009) 1.11
Economics of neuraminidase inhibitor stock piling for pandemic influenza, Singapore. Emerg Infect Dis (2006) 1.11
Influenza vaccines: from surveillance through production to protection. Mayo Clin Proc (2010) 1.09
Brief report: Influenza vaccination and health care workers in the United States. J Gen Intern Med (2006) 1.07
From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine (2011) 1.05
5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication. Virol J (2010) 1.02
Animal models for influenza viruses: implications for universal vaccine development. Pathogens (2014) 0.99
Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice. Clin Vaccine Immunol (2011) 0.98
A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide. Nat Protoc (2010) 0.98
Efficacy of the influenza vaccine in patients with malignant lymphoma. Clin Med Res (2005) 0.95
Influenza vaccination of persons with cardiovascular disease in the United States. Tex Heart Inst J (2004) 0.95
Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2004) 0.95
Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease. Tex Heart Inst J (2009) 0.95
Comparative immunogenicities of frozen and refrigerated formulations of live attenuated influenza vaccine in healthy subjects. Antimicrob Agents Chemother (2007) 0.95
Predictors of flu vaccination among urban Hispanic children and adults. J Epidemiol Community Health (2010) 0.92
Use of clinical decision support to increase influenza vaccination: multi-year evolution of the system. J Am Med Inform Assoc (2008) 0.91
Secondary household transmission of 2009 pandemic influenza A (H1N1) virus among an urban and rural population in Kenya, 2009-2010. PLoS One (2012) 0.89
Benefits of influenza vaccination during pregnancy for pregnant women. Am J Obstet Gynecol (2012) 0.88
An audit of influenza vaccination status in adults with inflammatory bowel disease. Can J Gastroenterol (2012) 0.87
Influenza-like illness among university students: symptom severity and duration due to influenza virus infection compared to other etiologies. J Am Coll Health (2011) 0.87
The provision of pharmaceutical advice improves patient vaccination status. Pharm Pract (Granada) (2006) 0.86
Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study. Hum Vaccin Immunother (2013) 0.85
Economies of scale in the production of public health services: an analysis of local health districts in Florida. Am J Public Health (2015) 0.85
Preventing influenza in healthy adults: the evolving story. JAMA (2000) 0.85
Reasons for and against receiving influenza vaccination in a working age population in Japan: a national cross-sectional study. BMC Public Health (2013) 0.83
Control of influenza. Tex Heart Inst J (2004) 0.83
Bacterially produced recombinant influenza vaccines based on virus-like particles. PLoS One (2013) 0.83
Protective efficacy and immunogenicity of a combinatory DNA vaccine against Influenza A Virus and the Respiratory Syncytial Virus. PLoS One (2013) 0.82
Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development. Biomed Res Int (2014) 0.82
Options and obstacles for designing a universal influenza vaccine. Viruses (2014) 0.82
Comparing estimates of influenza-associated hospitalization and death among adults with congestive heart failure based on how influenza season is defined. BMC Public Health (2008) 0.82
Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines. J Infect Dis (2014) 0.82
Supplementation of elderly Japanese men and women with fucoidan from seaweed increases immune responses to seasonal influenza vaccination. J Nutr (2013) 0.82
Workplace vaccination and other factors impacting influenza vaccination decision among employees in Israel. Int J Environ Res Public Health (2010) 0.82
Influenza vaccination in cancer patients undergoing systemic therapy. Clin Med Insights Oncol (2014) 0.81
An innovative influenza vaccination policy: targeting last season's patients. PLoS Comput Biol (2014) 0.81
Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines. Hum Vaccin Immunother (2013) 0.81
Prevention and control of influenza in persons with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2007) 0.80
Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus? Can J Gastroenterol (2010) 0.80
Development and psychometric validation of a self-administered questionnaire assessing the acceptance of influenza vaccination: the Vaccinees' Perception of Injection (VAPI) questionnaire. Health Qual Life Outcomes (2009) 0.80
Prospects of HA-based universal influenza vaccine. Biomed Res Int (2015) 0.79
Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults. Hum Vaccin (2011) 0.79
Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses. PLoS One (2015) 0.79
Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Hum Vaccin Immunother (2013) 0.78
Fighting misconceptions to improve compliance with influenza vaccination among health care workers: an educational project. PLoS One (2012) 0.78
Policy resistance undermines superspreader vaccination strategies for influenza. PLoS Comput Biol (2013) 0.78
Factors associated with uptake of influenza vaccine in people aged 50 to 64 years in Hong Kong: a case-control study. BMC Public Health (2015) 0.78
Influenza vaccination in the elderly: why are the overall benefits still hotly debated? J Prev Med Hyg (2015) 0.77
Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients. Int J Chron Obstruct Pulmon Dis (2007) 0.77
Influenza vaccine for healthy working adults. JAMA (2001) 0.77
A cost-benefit analysis of testing for influenza A in high-risk adults. Ann Fam Med (2004) 0.77
Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells. Vaccine (2015) 0.76
Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry Clin Neurosci (2001) 36.50
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science (1998) 19.40
Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet (1997) 13.93
Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol (1999) 11.94
The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis (1997) 9.69
Ordered metal nanohole arrays made by a two-step replication of honeycomb structures of anodic alumina. Science (1995) 8.78
Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis (1998) 8.51
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J Virol (2000) 8.28
Accurate inference of relationships in sib-pair linkage studies. Am J Hum Genet (1997) 7.78
Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology (1999) 7.32
Predicting the evolution of human influenza A. Science (1999) 6.91
Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med (2000) 6.83
Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1) Nature (1996) 6.72
A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58
Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA (1998) 6.43
Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance. Nature (1988) 6.35
A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol (1999) 6.03
Long term trends in the evolution of H(3) HA1 human influenza type A. Proc Natl Acad Sci U S A (1997) 5.76
The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis (1999) 5.39
Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol (1990) 5.37
Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A (2000) 5.36
Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) Nature (1996) 5.32
Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest (1999) 5.30
Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol (1999) 4.97
Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature (1986) 4.97
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis (1999) 4.67
Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis (1999) 4.59
The impact of influenza epidemics on hospitalizations. J Infect Dis (2000) 4.28
Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother (2003) 3.90
Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol (1983) 3.70
CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol (2000) 3.63
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis (2000) 3.63
The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology (1986) 3.34
A method for timely assessment of influenza-associated mortality in the United States. Epidemiology (1997) 3.31
Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology (1999) 3.16
The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics. Clin Pharmacol Ther (2012) 3.15
PNAD-CSS: a workbench for constructing a protein name abbreviation dictionary. Bioinformatics (2000) 2.98
Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation (1999) 2.80
A second-generation genomewide screen for asthma-susceptibility alleles in a founder population. Am J Hum Genet (2000) 2.62
Genome-wide search for asthma susceptibility loci in a founder population. The Collaborative Study on the Genetics of Asthma. Hum Mol Genet (1998) 2.57
Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet (1995) 2.54
Observations on mortality during the 1918 influenza pandemic. Clin Infect Dis (2001) 2.54
The importance of genealogy in determining genetic associations with complex traits. Am J Hum Genet (2001) 2.46
Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution. Proc Natl Acad Sci U S A (2000) 2.42
Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. Nucleic Acids Res (1983) 2.41
Location of functional regions of acetylcholine receptor alpha-subunit by site-directed mutagenesis. Nature (1985) 2.40
Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA (2000) 2.35
Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans. J Med Virol (2002) 2.35
Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study. Ophthalmology (1998) 2.26
Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. J Gen Virol (2001) 2.15
A laboratory model to evaluate cutout resistance of implants for pertrochanteric fracture fixation. J Orthop Trauma (2004) 2.13
A simulation model for assessing aberration detection methods used in public health surveillance for systems with limited baselines. Stat Med (2005) 2.10
Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza. J Clin Microbiol (1989) 2.09
The concentric structure of the developing gut is regulated by Sonic hedgehog derived from endodermal epithelium. Development (2000) 2.03
Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J Infect Dis (1999) 2.02
Location of a delta-subunit region determining ion transport through the acetylcholine receptor channel. Nature (1987) 1.99
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.99
Fluid-attenuated inversion recovery intraarterial signal: an early sign of hyperacute cerebral ischemia. AJNR Am J Neuroradiol (2001) 1.98
Decline in sex ratio at birth after Kobe earthquake. Hum Reprod (1998) 1.98
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2001) 1.97
Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet (2000) 1.94
Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. J Gen Virol (1993) 1.92
Recombination of human influenza A viruses in nature. Nature (1980) 1.92
Laboratory-based surveillance of influenza A(H1N1) and A(H3N2) viruses in 1980-81: antigenic and genomic analyses. Bull World Health Organ (1983) 1.89
A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet (1998) 1.87
Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet (1998) 1.87
A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest (2000) 1.85
Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Mol Psychiatry (2012) 1.84
Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis (1995) 1.84
Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine (1995) 1.83
Biomechanical study of the ligamentous system of the acromioclavicular joint. J Bone Joint Surg Am (1986) 1.82
Type- and subtype-specific detection of influenza viruses in clinical specimens by rapid culture assay. J Clin Microbiol (1995) 1.80
Long-term follow-up of functional outcomes and radiographic changes at adjacent levels following lumbar spine fusion for degenerative disc disease. Eur Spine J (2001) 1.77
Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol (2001) 1.75
Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry (1997) 1.71
Right-sided ovulation favours pregnancy more than left-sided ovulation. Hum Reprod (2000) 1.71
Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science (1986) 1.70
The epidemiology of chronic fatigue in San Francisco. Am J Med (1998) 1.69
Arterial false aneurysms and their modern management. Isr Med Assoc J (2001) 1.66
Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet (1998) 1.65
An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza. J Virol (1994) 1.65
Role of acetylcholine receptor subunits in gating of the channel. Nature (1986) 1.63